- Parties: The plaintiffs were Bayer Inc., Bayer Healthcare LLC, and Regeneron Pharmaceuticals Inc. The defendants were Celltrion, Inc., Celltrion Healthcare Canada Ltd, Celltrion Healthcare Co Ltd, Celltrion Pharm Inc.

- Subject Matter: This action involved the Patented Medicines (NOC) Regulations. This case is ongoing.

- Date: The hearing was set on May 27, 2024.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.